Showing 1 - 20 results of 35 for search 'Vieta, E', query time: 0.05s
Refine Results
-
1
Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. by Goodwin, G, Martinez-Aran, A, Glahn, D, Vieta, E
Published 2008Journal article -
2
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses by Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF
Published 2015-12-01
Article -
3
-
4
-
5
-
6
-
7
-
8
Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia by Culpepper L, Vieta E, Kelly DL, Patel MD, Szatmári B, Hankinson A, Earley WR
Published 2022-05-01
Article -
9
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder by Vieta, E., Montgomery, S., Sulaiman, A.H., Cordoba, R., Huberlant, B., Martinez, L., Schreiner, A.
Published 2012
Article -
10
Alzheimer's disease and cancer: Current epidemiological evidence for a mutual protection by Catalá-López, F, Crespo-Facorro, B, Vieta, E, Valderas, J, Valencia, A, Tabarés-Seisdedos, R
Published 2014Journal article -
11
Alzheimer's disease and cancer: current epidemiological evidence for a mutual protection. by Catalá-López, F, Crespo-Facorro, B, Vieta, E, Valderas, J, Valencia, A, Tabarés-Seisdedos, R
Published 2014Journal article -
12
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bi... by Grunze, H, Vieta, E, Goodwin, G, Bowden, C, Licht, R, Azorin, J, Yatham, L, Mosolov, S, Möller, H, Kasper, S
Published 2017Journal article -
13
ECNP consensus meeting. Bipolar depression. Nice, March 2007. by Goodwin, G, Anderson, I, Arango, C, Bowden, C, Henry, C, Mitchell, P, Nolen, W, Vieta, E, Wittchen, H
Published 2008Journal article -
14
Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (... by Rosa, A, Singh, N, Whitaker, E, de Brito, M, Lewis, A, Vieta, E, Churchill, G, Geddes, J, Goodwin, G
Published 2014Journal article -
15
Relating mood to plasma glutathione and BDNF levels in patients with bipolar disorder by Singh, N, Rosa, A, Whitaker, E, de Britto, M, Lewis, A, Vieta, E, Churchill, G, Geddes, J, Goodwin, G
Published 2013Conference item -
16
The effectiveness of adjunct mindfulness-based intervention in treatment of bipolar disorder: A systematic review and meta-analysis. by Chu, C, Stubbs, B, Chen, T, Tang, C, Li, D, Yang, W, Wu, C, Carvalho, A, Vieta, E, Miklowitz, D, Tseng, P, Lin, P
Published 2017Journal article -
17
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review by Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF
Published 2017-06-01
Article -
18
-
19
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance. by Goodwin, G, Abbar, M, Schlaepfer, T, Grunze, H, Licht, R, Bellivier, F, Fountoulakis, K, Altamura, A, Pitchot, W, Ågren, H, Holsboer-Trachsler, E, Vieta, E
Published 2011Journal article -
20
Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey by van der Feltz-Cornelis CM, van Os J, Knappe S, Schumann G, Vieta E, Wittchen HU, Lewis SW, Elfeddali I, Wahlbeck K, Linszen D, Obradors-Tarragó C, Haro JM
Published 2014-06-01
Article